Jordi Martínez

GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study

Andrés López, Antonio Gutiérrez, Andrés Palacios et al. · European Journal Of Haematology · 2007 · 110 citations

Medicine, Hematology, Oncology +14

Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval

Jordi Martínez, Oliver Vögler, Jesús Casas et al. · Molecular Pharmacology · 2004 · 77 citations

Life Sciences, Oncology, Pharmacology +17

Minerval induces apoptosis in Jurkat and other cancer cells

Victoria Lladó, Antonio Gutiérrez, Jordi Martínez et al. · Journal of Cellular and Molecular Medicine · 2008 · 56 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma

José Rodríguez, Antonio Gutiérrez, Andrés Palacios et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 49 citations

Medicine, Hematology, Oncology +15

The Repression of E2F-1 Is Critical for the Activity of Minerval against Cancer

Jordi Martínez, Antonio Gutiérrez, Jesús Casas et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 42 citations

Medicine, Oncology, Pharmacology +17